The negative change in turnover (-0.83%) and the slight slowdown in exports was accompanied by yet another negative performance for the pharmacy channel with -5.3% in 2012. Numbers, forecasts and recipes at the center of the 'Innovate to Grow' meeting organized in Tirrenia (Pisa) by Asis.
23 MAR – For the pharmaceutical sector, it is dramatically urgent to identify strategies to deal with the stagnation of the sector and to start growing again in a world panorama destined to register a slowdown in the next four years, if not even a decline in the European markets.
Predictions and recipes for tackling the crisis are at the center of the meeting organized in Tirrenia (Pisa) by Asis (Association of Health Industry Studies) from 21 to 23 March, with the patronage of the Province, the Municipality and the University of Pisa, of the Tuscan district of Life Sciences and of the main sector associations: Farmindustria, Assobiotec, Assogenerici, Aschimfarma, Federfarma, Federsalus and Pharmintech.
“The crisis seems to have taken over, but all the interlocutors who agreed to participate in these study days are instead convinced that the Italian system, and with it the pharmaceutical sector, can restart”, he explains Marco Macchia, president of Asis and president of the degree course in Chemistry and Pharmaceutical Technologies at the University of Pisa. "The problem is being able to interpret without prejudice the solicitations and the need for change in a sector such as that of Health, which is already undergoing drastic transformations and which will force all the protagonists to adapt".
Crisis that has serious consequences on drug companies. “We can start again – he specifies Massimo Scaccabarozzi, president of Farmindustria (ALSO SEE SLIDES FOR FURTHER INFORMATION)– focusing on innovation. Quality typical of the pharmaceutical sector which has 6,000 employees in Research, 1,